Olema Pharmaceuticals, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods Sold | 119K | 187K | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | -119K | -187K | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D Expenses | 49.2M | 43.2M | 40.0M | 43.9M | 30.6M | 32.3M | 33.2M | 29.1M |
| Operating Expenses | 57.9M | 49.9M | 45.9M | 47.9M | 34.9M | 36.8M | 37.6M | 33.5M |
| Operating Income | -58.0M | -50.1M | -45.9M | -47.9M | -34.9M | -36.8M | -37.6M | -33.5M |
| Other Income / Gains | 4.9M | 4.0M | 3.7M | 4.1M | 4.5M | 3.2M | 3.1M | 3.1M |
| Net Income | -53.1M | -46.1M | -42.2M | -43.8M | -30.4M | -33.6M | -34.6M | -30.4M |
| EPS (Diluted) | -0.52 | -0.50 | -0.49 | -0.51 | -0.36 | -0.57 | -0.60 | -0.54 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General And Administrative Expenses | 8.8M | 6.9M | 5.9M | 4.0M | 4.2M | 4.5M | 4.4M | 4.4M |
| Selling And Marketing Expenses | -119K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 8.6M | 6.9M | 5.9M | 4.0M | 4.2M | 4.5M | 4.4M | 4.4M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 58.0M | 50.1M | 45.9M | 47.9M | 34.9M | 36.8M | 37.6M | 33.5M |
| Interest Income | 4.8M | 4.0M | 3.6M | 4.0M | 4.5M | 3.3M | 2.9M | 3.1M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 119K | 187K | 43K | 132K | 128K | 116K | 95K | 94K |
| Ebitda | -53.0M | -45.9M | -42.2M | -43.7M | -30.3M | -33.5M | -34.5M | -30.3M |
| Ebitdaratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | -53.1M | -46.1M | -42.2M | -43.8M | -30.4M | -33.6M | -34.6M | -30.4M |
| Income Before Tax Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Epsdiluted | -0.52 | -0.51 | -0.49 | -0.51 | -0.36 | -0.57 | -0.60 | -0.54 |
| Weighted Average Shs Out | 102.8M | 91.3M | 85.7M | 85.5M | 85.4M | 58.7M | 57.3M | 56.3M |
| Weighted Average Shs Out Dil | 102.8M | 91.3M | 85.7M | 85.5M | 85.4M | 58.7M | 57.3M | 56.3M |